Psoriasis is a common chronic inflammatory skin disease, associated with substantial
comorbidity. TH17 lymphocytes, differentiating under the influence of dendritic cell-derived …

Psoriasis is an immune-mediated disease with a strong genetic component that brings many
challenges to sick individuals, such as chronic illness, and which has multiple associated …

In recent years, the use of interleukin (IL) 23 inhibitors in the treatment of psoriatic arthritis
(PsA) has been the subject of much research. By specifically binding to the p19 subunit of IL …

Background The coexistence of psoriasis and hidradenitis suppurativa (HS) has been
described, but the association between these conditions is yet to be firmly established …

Psoriasis is an autoimmune, chronic, inflammatory skin condition mediated by T cells. It
differs from other inflammatory conditions by causing significant alterations in epidermal cell …

Exceptional advances have been made with systemic treatment for psoriasis (PSO).
However, that disease still represents a heavy burden in terms of impact on healthcare …

Psoriatic arthritis (PsA) is a heterogeneous disease that may develop in up to 30% of
patients with psoriasis. PsA mainly involves peripheral joints; however, axial skeleton and …

Psoriasis is a chronic and multifactorial skin disease which is caused by inflammatory
infiltrates, keratinocyte hyperproliferation, and accumulation of immune cells. As part of the …

Psoriasis is a chronic multisystemic inflammatory disease with inflammatory cell infiltration,
hyperproliferation of keratinocytes in skin lesions, and epidermal barrier dysfunction. Normal …

Topical imiquimod based creams are indicated as immune stimulants for papillomas and
various skin neoplasms. Imiquimod is considered a TLR7 ligand. These creams are also …